טוען...

Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

BACKGROUND: Most patients with malignant peritoneal mesothelioma (MPM) present with late-stage, unresectable disease that responds poorly to systemic chemotherapy while, at the same time, effective targeted therapies are lacking. We assessed the efficacy of cytoreductive surgery (CRS) and hypertherm...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Magge, Deepa, Zenati, Mazen S., Austin, Frances, Mavanur, Arun, Sathaiah, Magesh, Ramalingam, Lekshmi, Jones, Heather, Zureikat, Amer H., Holtzman, Matthew, Ahrendt, Steven, Pingpank, James, Zeh, Herbert J., Bartlett, David L., Choudry, Haroon A.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2013
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4100549/ https://ncbi.nlm.nih.gov/pubmed/24322529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-3358-y
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis

פריטים דומים